Table of contents

Electronic pages

• Correspondence on ‘prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis’ (10 November, 2020)

  Jiyuan Shi, Ya Gao, Lili Zhang, Yang Zhao, Jianguo Xu, Jinhui Tian
• Response to ‘Correspondence on ‘Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis’’ by Shi et al

  (10 November, 2020)

  Shintaro Akiyama, Shadi Hamdeh, Dejan Micic, Atsushi Sakuraba
• Correspondence on ‘Impact of COVID-19 pandemic on patients with large-vessels vasculitis in Italy: a monocentric survey’ (12 November, 2020) Free

  Cloé Comarmond, Mathilde Leclercq, Gaëlle Leroux, Cindy Marques, Alexandre Le Joncour, Fanny Domont, Céline Hatte, Ségolène Toquet-Bouedec, Perrine Guillaume-Jugnot, Anne-Claire Desbois, Mathieu Vautier, Aude Rigolet, Yves Allenbach, Olivier Benveniste, David Saadoun, Patrice Cacoub
• Response to: ‘Correspondence on ‘Impact of COVID-19 pandemic on patients with large-vessels vasculitis in Italy: a monocentric survey’ by Comarmond et al

  (12 November, 2020)

  Alessandro Tomelleri, Silvia Sartorelli, Elena Marina Baldissera, Lorenzo Dagna, Corrado Campochiaro
• Correspondence on ‘Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort’ (11 November, 2020)

  Adeline Ruyssen-Witrand, Martin Soubrier, André Basch, Marie-Elise Truchetet, Raphaèle Seror
• Response to ‘Correspondence on ‘Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort’ by Ruyssen-Witrand et al

  (11 November, 2020)

  Adrian Ciurea, Axel Finckh
• Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study’ (14 December, 2020)

  Enrique Calvo-Aranda, Irene Cañamares-Orbis, Marta Novella-Navarro, Alvaro Martinez-Alcala, Maria del Carmen Ortega de la O, Ismael Escobar-Rodriguez, Fernando Manuel Sanchez-Aranda
• Response to: ‘Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19- associated cytokine storm syndrome: results of the CHIC study’’ by Calvo-Aranda et al

  (14 December, 2020)

  Sofia Ramiro, Rémy Mostard, Robert BM Landewé
• Correspondence on ‘Systemic sclerosis and the COVID-19 pandemic—World Scleroderma Foundation preliminary advice for patient management’ (6 January, 2021)

  Elena Snarskaya, Kseniia Vasileva
• Response to: ‘Correspondence on ‘Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management’’ by Snarskaya and Vasileva (6 January, 2021)

  Cosimo Bruni, Marco Matucci-Cerinic
• Serological tests confirm the low incidence of COVID-19 in chronic rheumatic inflammatory diseases treated with biological DMARD (6 July, 2020)

  Maurizio Benucci, Arianna Damiani, Gianfranco Giannasi, Francesca Li Gobbi, Luca Quartuccio, Valentina Grossi, Maria Infantino, Mariangela Manfredi
• Impact of lockdown on rheumatology outpatient care in the age of COVID-19 (7 August, 2020)

  Benjamin Sachdev Manjit Singh, Seow Lin Chuah, Yaw Kiet Cheong, Sharifah Aishah Wan, Cheng Lay Teh
• Correspondence on ‘EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups’ (13 January, 2021) Free

  Irfan Mohammad, Phani Kumar Devarasetti, Liza Rajasekhar
• Response to: ‘Correspondence on ‘EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups’’ by Irfan et al

  (13 January, 2021) Free

  Ingrid E Lundberg, Frederick W Miller, Lisa G Rider, Victoria P Werth, Anna Tjärnlund, Matteo Bottai
• Correspondence on ‘Novel ultrasonographic Halo Score for giant cell arteritis: assessment of diagnostic accuracy and association with ocular ischaemia’ (2 December, 2020) Free

  Gerasimos Evangelatos, George E Fragoulis, Alexios Iliopoulos
• Response to: ‘Correspondence on ‘Novel ultrasonographic Halo Score for giant cell arteritis: assessment of diagnostic accuracy and association with ocular ischaemia’’ by Evangelatos et al

  (2 December, 2020) Free

  Kornelis SM van der Geest, Bhaskar Dasgupta
• Correspondence on ‘EULAR recommendations for a core data set for pregnancy registries in rheumatology’ (25 November, 2020) Free

  Diederik De Cock, Isaline Soenen, Delphine Bertrand, Sofia Pazmino, Veerle Stouten, Rene Westhovens, Patrick Verschueren
• Response to: ‘Correspondence on ‘EULAR recommendations for a core data set for pregnancy registries in rheumatology” by De Cock et al

  (25 November, 2020) Free

  Yvette Meissner, Rebecca Fischer-Betz, Angela Zink, Anja Strangfeld
• Correspondence on ‘Incidence trend of five common musculoskeletal disorders from 1990 to 2017 at the global, regional and national level: results from the global burden of disease study 2017’ (2 December, 2020) Free

  Ping-Hao Chiang, Po-Chung Ju, Yun-Chi Chiang, James Cheng-Chung Wei
• Response to: ‘Correspondence on ‘Incidence trend of five common musculoskeletal disorders from 1990 to 2017 at the global, regional and national level: results from the Global Burden of Disease study 2017’ by Chiang et al

  (2 December, 2020) Free

  Ziyi Jin, Jinkou Zhao, Lingyun Sun
• Correspondence on ‘Critical role of neutrophil extracellular traps (NETs) in patients with Behcet’s disease’ (24 December, 2020) Free

  Jiali Chen, Tian Liu, Jing He, Yudong Liu
• Response to: ‘Correspondence on ‘Critical role of neutrophil extracellular traps (NETs) in patients with Behcet’s disease’’ by Chen et al

  (24 December, 2020) Free

  Alexandre Le Joncour, David Saadoun, Yacine Boulaftali
• Correspondence on ‘Prevotella copri in individuals at risk for rheumatoid arthritis’

  (3 December, 2020) Free

  Tianyue Sun, Jing Ni
• Response to: ‘Correspondence on ‘Prevotella copri in individuals at risk for rheumatoid arthritis’’ by Sun and Ni

  (3 December, 2020) Free

  Benoît Thomas P Gilbert, Axel Finckh, Deshire Alpizar Rodriguez
• Correction: 2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis

  (23 January, 2023) Free
• Correction: Loss of balance between protective and pro-inflammatory synovial tissue T-cell polyfunctionality predates clinical onset of rheumatoid arthritis

  (23 January, 2023) Free
• Correction: Impact of biological therapy on work outcomes in patients with axial spondyloarthritis: results from the British Society for Rheumatology Biologics Register (BSRBR-AS) and meta-analysis

  (23 January, 2023) Free